Idenix Pharmaceuticals Inc

Type: Company
Name: Idenix Pharmaceuticals Inc
Nationality: United States
Web Address: http://www.idenix.com/
First reported 8 hours ago - Updated 17 mins ago - 2 reports

UPDATE 3-Merck quarterly profit beats estimates; shares gain

(Adds comments from CEO, analysts, details on drug pipeline)July 29 (Reuters) - Merck & Co Inc reported better-than-expected quarterly results on Tuesday, helped by strong sales of consumer products and medicines for arthritis and HIV, sending its shares ... [Published CNBC - 7 hours ago]
First reported 3 hours ago - Updated 3 hours ago - 1 reports

Merck's (MRK) CEO Lynn Fuller on Q2 2014 Results - Earnings Call Transcript

OperatorGood day everyone, and welcome to Merck’s Second Quarter 2014 Earnings Conference Call. Today’s call is being recorded. At this time I’d like to turn the call over to Joseph Romanelli, Vice President of Investor Relations. Please go ahead.Joseph ... [Published Seeking Alpha - 3 hours ago]
First reported 5 hours ago - Updated 5 hours ago - 1 reports

Merck beats Q2 earnings estimates, but mostly on cost-cutting

Merck ($MRK) surprised Wall Street analysts today when it announced that its net profit in the second quarter jumped to $2 billion from $906 million in the same period a year ago, and that it was raising the lower end of its income forecast for 2014. ... [Published FiercePharma - 5 hours ago]
First reported 10 hours ago - Updated 10 hours ago - 1 reports

Merck Quarterly Profit Beats Analysts’ Estimates on Cost Cuts

Merck & Co. (MRK) , the second-biggest U.S.drugmaker by sales, reported second-quarter profit that beatanalysts’ estimates as the company cut costs.Net income more than doubled to $2 billion, or 68 cents ashare, from $906 million, or 30 cents, a year ... [Published Bloomberg - 10 hours ago]
First reported 12 hours ago - Updated 12 hours ago - 1 reports

Today In SA PRO: Monday, July 28

Top Idea: Coupons.Com by New Capital: Short / Technology - Internet Information Providers / Value / Small-Cap / Overhyped / Newly Public Company / 55% DownsideTop Idea: Aeropostale by Jeremy Raper: Short / Services - Apparel Stores / Momentum / Small-Cap ... [Published Seeking Alpha - 12 hours ago]
First reported Jul 28 2014 - Updated Jul 28 2014 - 2 reports

Gilead Sciences, Inc. (GILD): The Bullish Case For The Stock

NASDAQ:GILD Related posts: Why I’m Bullish On Gilead Sciences, Inc. (GILD) Gilead Sciences, Inc. (GILD) Earnings Report Surprises The Market Gilead Sciences, Inc. (GILD): Biotech Bubble or Buying Opportunity? The Biggest Beneficiary Of Biotech’s Comeback ... [Published NewsOK.com - Jul 28 2014]
First reported Jul 28 2014 - Updated Jul 28 2014 - 1 reports

Announcing SA's First Outstanding Performance Award Winners

Summary We're announcing our first two outstanding performance award winners. Two authors who made great calls - on IDIX and on FNHC - will be receiving $2,500 awards each. Both calls played out well, were convincing, and nailed the thesis. We will ... [Published Seeking Alpha - Jul 28 2014]
First reported Jul 25 2014 - Updated Jul 25 2014 - 1 reports

Merck whacks 600 sales reps as part of 8,500 bloodletting

Merck is going through a complete makeover, buying and selling units at a rapid pace. And some of its employees are getting caught in its out with the old and in with the new philosophy. Now 600 sales reps have been told their services are no longer ... [Published FiercePharma - Jul 25 2014]
First reported Jul 23 2014 - Updated Jul 23 2014 - 1 reports

Havens Advisors Top New Positions: Covidien plc (COV), Idenix Pharmaceuticals Inc. (IDIX) and Others

In its recent 13F filing with the U.S. Securities and Exchange Commission, Nancy Havens-Hasty’s Havens Advisors has disclosed its long equity positions for the second quarter of 2014. The value of the fund’s equity portfolio amounted to $137.9 million, ... [Published InsiderMonkey.com - Jul 23 2014]
First reported Jul 17 2014 - Updated Jul 17 2014 - 1 reports

Idenix Pharmaceuticals Short Interest Down 17.7% in June (IDIX)

Idenix Pharmaceuticals (NASDAQ:IDIX) was the recipient of a significant decline in short interest in the month of June. As of June 30th, there was short interest totalling 13,878,933 shares, a decline of 17.7% from the June 13th total of 16,866,953 shares, ... [Published American Banking News - Jul 17 2014]
First reported Jul 10 2014 - Updated Jul 10 2014 - 2 reports

The Biggest Beneficiary Of Biotech’s Comeback

NASDAQ:GILD, NASDAQ:IDIX, NYSE:MRK Related posts: Biotechs With Big Upside [Gilead Sciences, Inc., Biogen Idec Inc, Alexion Pharmaceuticals, Inc., Celgene Corporation, Novartis AG (ADR)] Hepatitis C and Merck [Merck & Co., Inc., Gilead Sciences, Inc.] ... [Published Crawford Financial Planning - Jul 10 2014]
First reported Jul 03 2014 - Updated Jul 03 2014 - 2 reports

Merck, Gilead Lead Race To Eradicate Hepatitis C

From last December's record-breaking launch ofGilead Sciences ' ( GILD ) wonder drug Sovaldi to the controversies about its $84,000 price tag toMerck 's ( MRK ) recent $3.85 billion buyout of formerly neglected biotechIdenix Pharmaceuticals ( IDIX ), ... [Published Nasdaq - Jul 03 2014]

Quotes

"They reorganized, took some bold steps and I think those are now starting to pay off."
...full value for AstraZeneca based on the information that was available to us," Ian Read, chairman and CEO of PFE said in a May press release. "As we said from the start, the pursuit of this transaction was a potential enhancement to our existing strategy."
"Merck will likely have another flattish year in 2014 in terms of financial performance but then growth should return more consistently thereafter" helped by new drugs, Sanford Bernstein analyst Tim Anderson said in a research note
The litigation "speaks to the blockbuster aspect of this drug [Sovaldi], both from a scientific standpoint and obviously from a monetary standpoint, that we're seeing very involved litigation from many different players" lawyer Theresa Kavanaugh, told the WSJ...

More Content

All (187) | News (114) | Reports (0) | Blogs (52) | Audio/Video (0) | Fact Sheets (1) | Press Releases (18)
sort by: Date | Relevance
Merck touts pipeline of new drugs amid sharpene... [Published Star Ledger - 17 mins ago]
Merck (MRK) Shares Rise, Pfizer (PFE) Stock Slu... [Published Money Morning - 32 mins ago]
Merck's (MRK) CEO Lynn Fuller on Q2 2014 Result... [Published Seeking Alpha - 3 hours ago]
Merck beats Q2 earnings estimates, but mostly o... [Published FiercePharma - 5 hours ago]
UPDATE 3-Merck quarterly profit beats estimates... [Published CNBC - 7 hours ago]
UPDATE 2-Merck Q2 profit tops estimates on stro... [Published CNBC - 8 hours ago]
Merck Q2 Results Beat Estimates, Lifts FY14 Ear... [Published RTTNews.com - 9 hours ago]
Merck Quarterly Profit Beats Analysts’ Estimate... [Published Bloomberg - 10 hours ago]
Today In SA PRO: Monday, July 28 [Published Seeking Alpha - 12 hours ago]
Gilead Sciences, Inc. (GILD): The Bullish Case ... [Published NewsOK.com - Jul 28 2014]
Why I’m Bullish On Gilead Sciences, Inc. (GILD) [Published Minyanville - Jul 28 2014]
Wall Street Breakfast: Tax Inversions, Solar Ta... [Published Seeking Alpha - Jul 28 2014]
Announcing SA's First Outstanding Performance A... [Published Seeking Alpha - Jul 28 2014]
Merck whacks 600 sales reps as part of 8,500 bl... [Published FiercePharma - Jul 25 2014]
Havens Advisors Top New Positions: Covidien plc... [Published InsiderMonkey.com - Jul 23 2014]
Puma Pumps up Biotech ETFs [Published Yahoo! Finance - Jul 23 2014]
Focus on complementary products to develop exis... [Published Express Pharma - Jul 22 2014]
Lucrative Drug Niche Sparks Legal Scramble [Published FirstWord Pharma - Jul 21 2014]
Gilead litigation says claims by Merck, AbbVie ... [Published FiercePharma - Jul 21 2014]
Stocks To Watch: Idenix, Cemex, GoPro... [Published Seeking Alpha - Jul 18 2014]
Hottest Healthcare Stocks Now – SHPG ISRG AGN IDIX [Published InvestorPlace.com - Jul 18 2014]
Idenix Pharmaceuticals Short Interest Down 17.7... [Published American Banking News - Jul 17 2014]
Turnaround Stories Lead Reni Benjamin's Biotech... [Published Stockboard Media Inc. - Jul 16 2014]
Deal frenzy transforming world pharma [Published Ireland Business World - Jul 14 2014]
3 Health Care Stocks Primed For Big Moves [Published Yahoo! Finance - Jul 14 2014]
Why American Apparel, Glu Mobile, and Achillion... [Published Daily Finance - Jul 11 2014]
June's top stories: 75 US staff possibly expose... [Published Pharmaceutical Technology - Jul 11 2014]
Biotechnology Stocks Technical Review -- Resear... [Published PR Newswire: Financial Services - Jul 11 2014]
The Biggest Beneficiary Of Biotech’s Comeback [Published Crawford Financial Planning - Jul 10 2014]
The Biotech Bull Market Is Far From Over [Published Crawford Financial Planning - Jul 10 2014]
1 2 3 4 5 6 7
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Biotechnology Stocks Technical Review -- Resear... [Published PR Newswire: Financial Services - Jul 11 2014]
LONDON, July 11, 2014 /PRNewswire/ --On Thursday, July 10, 2014, the NASDAQ Composite ended at 4,396.20, down 0.52%, the Dow Jones Industrial Average finished the session at 16,915.07, down 0.42% and the S&P 500 closed at 1,964.68, down 0.41%. During ...
Merck initiates tender offer to acquire Idenix [Published PBR - News - Jun 23 2014]
Merck (MRK), known as MSD outside the United States and Canada, is commencing, through a subsidiary, a cash tender offer to purchase all outstanding shares of common stock of Idenix Pharmaceuticals, Inc. (IDIX). On June 09, 2014, Merck announced its intent ...
Merck Begins Tender Offer to Acquire Idenix [Published Business Wire Health News - Jun 20 2014]
WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck is commencing today, through a subsidiary, a cash tender offer to purchase all outstanding shares of common stock of Idenix Pharmaceuticals, Inc. ...
Idenix Pharmaceuticals Cut to Neutral from Buy ... [Published BARRONS.com Stocks To Watch Today - Jun 19 2014]
Idenix Pharmaceuticals (IDIX), whose share jumped 230% in one day earlier this month when Merck (MRK) announced that it would buy biotech company for its hepatitis C treatment, has been cut to Neutral from Buy at UBS this evening. UBS analyst Matthew ...
SHAREHOLDER ALERT: Brower Piven Announces The I... [Published EON Business - Jun 17 2014]
STEVENSON, Md.--(EON: Enhanced Online News)--The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty to current shareholders of Idenix Pharmaceuticals, Inc. ...
1 2 3 4 5 6 7 8 9 10 ...

Press Releases

sort by: Date | Relevance
The Zacks Analyst Blog Highlights: AbbVie, Gile... [Published Financial Services - Jun 17 2014]
SHAREHOLDER ALERT: Brodsky & Smith, LLC Announc... [Published Financial Services - Jun 13 2014]
SHAREHOLDER ALERT: Pomerantz LLP Investigates C... [Published Financial Services - Jun 13 2014]
Study Results, Updated Organization Structures,... [Published Financial Services - Jun 05 2014]
Technical Analysis on Top Gainers -- Research o... [Published Financial Services - Jun 03 2014]
1 2 3 4
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.